Navigation Links
High Hopes Pinned At Hungarian Bird Flu Vaccine

High hopes are being pinned at a bird flu vaccine being manufactured by the Hungarian government and a private company- Omninvest. Human trials in Hungary have shown the vaccine to work against the H5N1 type of avian influenza,// which has killed more than 60 people in Asia.

Even while the vaccine, which produced an immune reaction to the H5N1 strain of the virus when tested on people is at a very early stage of development, several countries have shown interest in buying the experimental bird flu vaccine, which Hungary will license by March, the government said.

According to spokesman Andras Batiz, 'The human trials started it all off, and we are past the first step after that, which means the manufacturing of 5,000 vaccines,' said.

As yet there are no firm orders and up to 25,000 vaccine shots first need to be made to test industrial production. The plant outside of Budapest would need investment to expand its capacity, Batiz said.

India, Indonesia, the Philippines and Russia are considering buying the know-how and setting up factories themselves, he said.

Experts fear that the H5N1 virus is on the verge of undergoing mutation, thus making it easier to spread from birds to humans. In the event of this happening the impact worldwide would be tremendous, experts say. And in the absence of a vaccine or drug against the bird flu, the loss of life would be unprecedented.

A vaccine for the current strain of H5N1 is already made experimentally by U.S. company Chiron Corp and French company Saonfi-Aventis among others. However, it is supposed that a vaccine would provide partial only protection against a pandemic strain of flu and would have to be reformulated to match whatever mutation eventually emerges - a process that would take months

Avian flu has affected the Southeast Asian nations although it is largely limited to poultry and wild-bird populations.

Page: 1

Related medicine news :

1. FDA Diminish Hopes On ‘Female Viagra
2. Hearing May Be Regained: Research Provides Hopes
3. India Hopes to Become Free of Bird Flu Soon
4. By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment
5. Effective Strategy Against Bird flu-Spainish Flu Vaccine Raises Hopes
6. Canadian Researchers Raise Hopes of Treatment for Memory Loss
7. Earth Day Celebrated With Hopes of a Greener Tomorrow
8. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
9. Hungarian Geese Slaughtered as Bird Flu Returns to EU
10. Hungarian Researchers Claim Cancer Breathalyzer Breakthrough
11. Vaccine to quit smoking?
Post Your Comments:

(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: